Oligorecurrent and Oligoprogressive Prostate Cancer Patients
1 clinical trials · Condition
◉ Watch Oligorecurrent and Oligoprogressive Prostate Cancer Patients
| Record | Firm | Date |
|---|---|---|
| Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT (NCT04624828) | Istituto Clinico Humanitas | 2020-10-19 |
Track Oligorecurrent and Oligoprogressive Prostate Cancer Patients automatically
Every clearance here is in the API, with alerts when new ones post.